Utah Medical Products Past Earnings Performance
Past criteria checks 3/6
Utah Medical Products has been growing earnings at an average annual rate of 6%, while the Medical Equipment industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 2.4% per year. Utah Medical Products's return on equity is 12.3%, and it has net margins of 34.6%.
Key information
6.0%
Earnings growth rate
6.6%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 2.4% |
| Return on equity | 12.3% |
| Net Margin | 34.6% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Utah Medical Products: Favorably Skewed Risk/Reward Profile
Dec 26Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30
Aug 06
Utah Medical Products: An Attractive, But Speculative, Prospect
Mar 22Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30
Feb 09Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30
Dec 13Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30
Nov 23Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.30
Nov 03Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of $0.295
Aug 28Do Utah Medical Products' (NASDAQ:UTMD) Earnings Warrant Your Attention?
Mar 04Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.295
Feb 10A Look At The Fair Value Of Utah Medical Products, Inc. (NASDAQ:UTMD)
Jan 11Utah Medical Products (NASDAQ:UTMD) Will Pay A Dividend Of $0.29
Aug 08Utah Medical Products declares $0.29 dividend
Aug 02Utah Medical Products GAAP EPS of $1.12, revenue of $13.4M
Jul 26Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29
May 14Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of US$0.29
Feb 26Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29
Feb 12Utah Medical Products (NASDAQ:UTMD) Could Be Struggling To Allocate Capital
Sep 28Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of US$0.28
Aug 06Shareholders Will Probably Not Have Any Issues With Utah Medical Products, Inc.'s (NASDAQ:UTMD) CEO Compensation
May 01Is Utah Medical Products, Inc. (NASDAQ:UTMD) An Attractive Dividend Stock?
Mar 26Here's What To Make Of Utah Medical Products' (NASDAQ:UTMD) Returns On Capital
Mar 02Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Feb 11Utah Medical Products (NASDAQ:UTMD) Shareholders Have Enjoyed A 47% Share Price Gain
Jan 27
Should You Review Recent Insider Transactions At Utah Medical Products, Inc. (NASDAQ:UTMD)?
Jan 13Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Shareholder Ownership Skewed Towards Insiders?
Dec 29Is Utah Medical Products, Inc. (NASDAQ:UTMD) A Smart Pick For Income Investors?
Dec 15Will Utah Medical Products (NASDAQ:UTMD) Multiply In Value Going Forward?
Nov 30Utah Medical Products declares $0.285 dividend
Nov 03Revenue & Expenses Breakdown
How Utah Medical Products makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 44 | 15 | 8 | 1 |
| 30 Jun 24 | 47 | 16 | 9 | 1 |
| 31 Mar 24 | 49 | 16 | 10 | 1 |
| 31 Dec 23 | 50 | 17 | 11 | 1 |
| 30 Sep 23 | 51 | 17 | 11 | 1 |
| 30 Jun 23 | 52 | 17 | 11 | 1 |
| 31 Mar 23 | 52 | 17 | 11 | 1 |
| 31 Dec 22 | 52 | 16 | 11 | 0 |
| 30 Sep 22 | 52 | 16 | 12 | 1 |
| 30 Jun 22 | 51 | 16 | 11 | 1 |
| 31 Mar 22 | 50 | 15 | 11 | 1 |
| 31 Dec 21 | 49 | 15 | 12 | 1 |
| 30 Sep 21 | 48 | 14 | 12 | 0 |
| 30 Jun 21 | 46 | 13 | 11 | 0 |
| 31 Mar 21 | 42 | 11 | 11 | 0 |
| 31 Dec 20 | 42 | 11 | 11 | 0 |
| 30 Sep 20 | 42 | 12 | 11 | 1 |
| 30 Jun 20 | 44 | 13 | 12 | 1 |
| 31 Mar 20 | 47 | 15 | 12 | 1 |
| 31 Dec 19 | 47 | 15 | 11 | 0 |
| 30 Sep 19 | 45 | 14 | 10 | 0 |
| 30 Jun 19 | 43 | 17 | 9 | 0 |
| 31 Mar 19 | 42 | 18 | 8 | 0 |
| 31 Dec 18 | 42 | 19 | 7 | 0 |
| 30 Sep 18 | 42 | 13 | 7 | 0 |
| 30 Jun 18 | 42 | 10 | 7 | 0 |
| 31 Mar 18 | 42 | 9 | 7 | 0 |
| 31 Dec 17 | 41 | 9 | 7 | 0 |
| 30 Sep 17 | 40 | 14 | 7 | 0 |
| 30 Jun 17 | 40 | 13 | 7 | 0 |
| 31 Mar 17 | 39 | 12 | 7 | 0 |
| 31 Dec 16 | 39 | 12 | 7 | 0 |
| 30 Sep 16 | 40 | 13 | 7 | 0 |
| 30 Jun 16 | 40 | 13 | 8 | 0 |
| 31 Mar 16 | 40 | 12 | 8 | 0 |
| 31 Dec 15 | 40 | 12 | 8 | 1 |
| 30 Sep 15 | 41 | 12 | 8 | 1 |
| 30 Jun 15 | 41 | 11 | 8 | 1 |
| 31 Mar 15 | 41 | 11 | 8 | 0 |
| 31 Dec 14 | 41 | 11 | 8 | 0 |
| 30 Sep 14 | 41 | 12 | 9 | 0 |
| 30 Jun 14 | 40 | 12 | 9 | 0 |
| 31 Mar 14 | 40 | 11 | 9 | 0 |
| 31 Dec 13 | 40 | 11 | 9 | 0 |
Quality Earnings: UTMD has high quality earnings.
Growing Profit Margin: UTMD's current net profit margins (34.6%) are higher than last year (32.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: UTMD's earnings have grown by 6% per year over the past 5 years.
Accelerating Growth: UTMD's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: UTMD had negative earnings growth (-9.7%) over the past year, making it difficult to compare to the Medical Equipment industry average (15%).
Return on Equity
High ROE: UTMD's Return on Equity (12.3%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 09:47 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Utah Medical Products, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Joseph Munda | Sidoti & Company, LLC |